Elective orthopedic procedures are among the most commonly performed surgeries. Although there is usually identifiable pathology (eg, osteoarthritis, degenerative disc disease, spinal stenosis) that could be considered an indication or these procedures, most are usually performed to reduce or eliminate pain and improve function.
It could be assumed that the efficacy of these procedures has been supported by high quality evidence, particularly randomized controlled trials (RCTs), but a recent umbrella review published in the British Medical Journalcalls this into question. Researchers examined meta-analyses of RCTs or of other study designs in absence of RCTs to compare the effectiveness of the 10 most common elective orthopedic procedures with no treatment, placebo, or non-operative care.
In the slides below, find a recap of the findings for each procedure and key takeaways for your clinical practice.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
An EHR-integrated tool matched manual CKD and cardiovascular risk assessments in 60 patients and showed promise for improving risk-based kidney care in primary care.
TMS 2026: Nearly 67% of US women receiving elinzanetant achieved at least a 50% reduction in menopausal VMS frequency by week 12 in pooled phase 3 trial data.
TMS 2026: Only 21.7% of women initiated menopause hormone therapy, with significant racial disparities and low treatment persistence, a new study finds.
TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found.
JoAnn Pinkerton, MD, discusses new research she presented at The Menopause Society 2026 Annual Meeting on elinzanetant for menopausal vasomotor symptoms.